Clinical Trials on Indication for Modification of Patient Cognitive Status in Netherlands
Total 7 results
-
A.G. HuppelschotenUnknownQuality of Life | Patient Centredness | Risk Factors for Emotional MaladjustmentNetherlands
-
Medtronic Cardiac Rhythm and Heart FailureCompletedClass I or II Indication for Implantation of a Single Chamber Ventricular Pacemaker According to ACC/AHA/HRS 2001 Guidelines and Any National GuidelinesUnited States, Netherlands, Japan, Serbia, Spain, Greece, Canada, India, Denmark, Czechia, South Africa, Malaysia, Austria, United Kingdom, Hungary, China, Australia, France, Italy
-
UMC UtrechtCompletedPatients Suspected for a Pancreatic (Pre-)MalignancyNetherlands
-
Amsterdam University Medical CenterEnrolling by invitationRetinoblastoma | Neurocognitive Dysfunction | Health-Related BehaviorNetherlands
-
AstraZenecaCompletedEGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies.Italy, Spain, United Kingdom, Sweden, Japan, Netherlands, Germany, France
-
Novartis PharmaceuticalsUniversity of PennsylvaniaRecruitingLong Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access ProgramUnited States, Japan, Australia, Germany, Spain, Belgium, Taiwan, Italy, Canada, Israel, Singapore, United Kingdom, Denmark, Finland, Norway, Austria, Netherlands, France
-
Erasmus Medical CenterUtrecht UniversityUnknownTuberous Sclerosis Complex | TSC Related Cognitive Disability | TSC Related Autism | TSC Related Learning ProblemsNetherlands